SANOFI
Sanofi is a healthcare company engaged in the research, development, manufacturing, and marketing of innovative therapeutic solutions. It covers areas such as diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new G enzyme. Its products includes prescriptions and over-the-counter drugs for thrombosis, cardiovascular disease, diabetes, central nervous system disorders, oncology and internal medicine, vaccines and other medical produc... ts. The two young groups Sanofi and Synthélabo merged in May 1999 to create a major new pharmaceutical player. Sanofi dates back to 1973 and Synthélabo to 1970. In December 1999, Rhône-Poulenc and Hoechst Marion Roussel formalized their merger with the creation of the Franco-German group Aventis, one of the world’s largest pharmaceutical companies. In August 2004, Sanofi-Synthelabo acquired Aventis. The takeover was finalized on December 31 of that year, giving birth to sanofi-aventis. On May 6, 2011, sanofi-aventis simplified its name to Sanofi. Sanofi  operates in over 100 countries throughout the world.
SANOFI
Industry:
Biotechnology Health Care Life Science Manufacturing Marketing Medical Pharmaceutical Therapeutics
Founded:
1973-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.sanofi.com
Total Employee:
10001+
Status:
Active
Contact:
800-981-2491
Email Addresses:
[email protected]
Total Funding:
639.02 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Google Tag Manager WordPress Content Delivery Network Domain Not Resolving Apache Nginx Amazon
Similar Organizations
adinotec AG
The adinotec AG with registered office in Griesheim (Germany) is active in the development, production, and marketing of innovative
Allergan France
Allergan France concentrates on manufacturing and marketing of originator pharmaceuticals.
Aseptic Technologies
Aseptic Technologies develops, manufactures and markets equipment.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
BioSystems
BioSystems researches, develops, produces and markets effective and reliable analytical systems for laboratories around the world.
CRYOFIT
CRYOFIT is involved in the research, development, and production of biological glue used during surgical intervention and medical processes.
Explera
Explera is engages in importing, manufacturing, and marketing products in the molecular biology field for research laboratories.
GABA International
GABA International is engaged in the research, development, manufacture, and marketing of oral care products.
Intana Bioscience GmbH
Lleading experts in customized assay development, screening and target/hit validation using fluorescence cross-correlation spectroscopy
JA Saúde Animal
J.A Saúde Animal specializes in research, development, manufacturing, and commercialization of products for animal health.
Jiangyuyi Chuang
Jiangyuyi Chuang engages in the research and development, manufacturing, and sales of medical testing equipment and smart wearable devices.
Kellsa Diagnostics
Kellsa Diagnostics are research, development, production and marketing of healthcare products and equipment, in particular diagnostics.
Phaseform
Phaseform develops next-generation adaptive optics systems based on innovative hardware and software
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-12-20 | Amunix | Amunix acquired by Sanofi | 1000 M USD |
| 2021-12-01 | Origimm | Origimm acquired by Sanofi | N/A |
| 2021-09-08 | Kadmon | Kadmon acquired by Sanofi | 1.9 B USD |
| 2021-08-03 | Translate Bio | Translate Bio acquired by Sanofi | 3.2 B USD |
| 2021-04-09 | Tidal Therapeutics | Tidal Therapeutics acquired by Sanofi | 160 M USD |
| 2021-01-11 | Kymab | Kymab acquired by Sanofi | 1.1 B USD |
| 2020-11-02 | Kiadis Pharma | Kiadis Pharma acquired by Sanofi | 308 M EUR |
| 2020-08-17 | Principia Biopharma | Principia Biopharma acquired by Sanofi | 3.68 B USD |
| 2019-12-09 | Synthorx | Synthorx acquired by Sanofi | 2.5 B USD |
| 2018-01-29 | Ablynx | Ablynx acquired by Sanofi | 3.9 B EUR |
Investors List
Blackstone Life Sciences
Blackstone Life Sciences investment in Post-IPO Equity - Sanofi
Evotec
Evotec investment in Post-IPO Equity - Sanofi
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-04 | Innovent Biologics | Sanofi investment in Post-IPO Equity - Innovent Biologics | 2.42 B HKD |
| 2022-07-12 | Areteia Therapeutics | Sanofi investment in Series A - Areteia Therapeutics | 350 M USD |
| 2022-01-10 | Exscientia | Sanofi investment in Post-IPO Equity - Exscientia | 100 M USD |
| 2021-11-18 | Owkin | Sanofi investment in Corporate Round - Owkin | 180 M USD |
| 2021-11-08 | Gyroscope Therapeutics | Sanofi investment in Corporate Round - Gyroscope Therapeutics | 60 M USD |
| 2021-02-16 | Novadiscovery | Sanofi investment in Series A - Novadiscovery | 2.5 M EUR |
| 2019-10-03 | Icosavax | Sanofi investment in Series A - Icosavax | 51 M USD |
| 2019-09-05 | Veralox Therapeutics | Sanofi investment in Seed Round - Veralox Therapeutics | 5.4 M USD |
| 2019-02-05 | Aetion | Sanofi investment in Series B - Aetion | 27 M USD |
| 2019-01-04 | BioNTech | Sanofi investment in Corporate Round - BioNTech | 80 M EUR |
Newest Events participated
Key Employee Changes
Official Site Inspections
http://www.sanofi.com Semrush global rank: 242.17 K Semrush visits lastest month: 290.85 K
- Host name: ec2-3-251-44-146.eu-west-1.compute.amazonaws.com
- IP address: 3.251.44.146
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Sanofi"
Our Company, pioneering pharmaceutical innovations | Sanofi
Sanofi, a global healthcare pharmaceutical company, is dedicated to improving lives through discovering, developing and delivering medicines and vaccines. Global pharmaceutical …See details»
Meet Our Executive Leadership Team - Sanofi
Sanofi - Wikipedia
Sanofi is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Biotechnology Industry Organization (BIO), and the Pharmaceutical Research and Manufacturers of America (PhRMA). Sanofi's vaccine subsidiary, Sanofi Pasteur, is a member of EuropaBio. In June 2021, Sanofi partnered with Capgemini, Orange & Generali to launch Future4care, an all-…See details»
Governance - Sanofi
Sanofi is a publicly traded, limited liability company, incorporated under French laws, guided by a visionary Board of Directors and Executive Committee. We are incorporated under the laws of …See details»
Our Company - Sanofi U.S.
The Sanofi of today is built on a heritage of turning the impossible into the possible for people and communities around the globe. Our Legacy MAT-US-2400483-v1.0-01/2024See details»
Sanofi Pharmaceuticals - Healthcare Innovations
Nov 15, 2024 Sanofi’s 340B Credit Model is an effort to bring this program back to its original intent. READ MORE. Lew celebrates his grandson's high school graduation with his family. A 9/11 Survivor’s Triumph Over Leukemia & …See details»
Sanofi - LinkedIn
Sanofi | 4,175,330 followers on LinkedIn. We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries ...See details»
Healthcare Company Sanofi's Vision and Strategy
Explore how Sanofi's strategic focus on breakthrough science, immunology, and vaccines aims to transform medicine and create a positive societal impact. ... Our social impact strategy is differentiated from our peers, multi-faceted and …See details»
Sanofi Pasteur - Wikipedia
Sanofi Pasteur is the vaccines division of the French multinational pharmaceutical company Sanofi. Sanofi Pasteur is the largest company in the world devoted entirely to vaccines. It is …See details»
Sanofi Mission, Benefits, and Work Culture | Indeed.com
Sanofi is comprised of three core business units: Specialty Care, Vaccines and General Medicines. Consumer Healthcare will become a standalone business unit. Around the world, more than 100,000 people at Sanofi are dedicated to …See details»
Sanofi | World Economic Forum
Jan 5, 2024 The World Economic Forum is an independent international organization committed to improving the state of the world by engaging business, political, academic and other leaders …See details»
Sanofi Governance: Executive & Leadership Team Overview | Sanofi
Sanofi is a publicly traded, limited liability company, incorporated under French laws, guided by a visionary Board of Directors and Executive Committee. We are incorporated under the laws of …See details»
Our Leadership: Driving Excellence and Growth | Sanofi USA
Explore Sanofi's U.S. leadership in innovation and impact. Learn how our leaders drive forward-thinking strategies for a brighter future.See details»
Home - Foundation S - Sanofi
Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change. Download the press release. March 28, 2023. Foundation S signs an …See details»
Sanofi Canada is celebrating 110 years of innovative health …
Jan 30, 2024 During the last 110 years, Sanofi Canada has built a unique footprint and heritage in Canada. Sanofi employs over 2,000 people in Canada, collaborating across manufacturing, …See details»
Sanofi expands its social commitments, creates nonprofit unit to ...
PARIS, April 7, 2021 /PRNewswire/ -- In an open letter, Sanofi Chief Executive Officer Paul Hudson today outlined several key projects that the company will implement to increase the …See details»
Sanofi Canada: global healthcare and pharmaceutical company
Sanofi has strong foundations in Canada going back over a century, and operates world-leading R&D and biomanufacturing facilities in Toronto. Sanofi also operates an artificial intelligence …See details»
Press Room - Sanofi US News
Other affiliates of sanofi-aventis in the United States include Research & Development, sanofi pasteur vaccines, BiPar and Chattem, the company’s consumer healthcare business. Sanofi …See details»
Sanofi unveils new corporate brand and logo – unites the …
Feb 3, 2022 Paul Hudson CEO of Sanofi “As we approach the half century mark of our company’s existence, we have undertaken the most important transformation and …See details»